Frontotemporal Degeneration (FTD): Community Perspectives on Clinical Trials
FTD care partners are integral stakeholders in successful clinical trials. Their perceptions of clinical trials and openness to facilitating enrollment of the person diagnosed are moderated by factors such as disease severity and trial burden. Researchers must ensure the perspectives of people impacted by FTD are accounted for in trial design.
Authors
- Shana G Dodge
- Carrie Milliard
- Penny A. Dacks
Institutions
- Association for Frontotemporal Degeneration (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.083598
- Primary Topic
- Amyotrophic Lateral Sclerosis Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00